Advertisement

Topics

Sienna Biopharmaceuticals Company Profile

03:01 EDT 19th June 2019 | BioPortfolio


News Articles [205 Associated News Articles listed on BioPortfolio]

The Verdict On Sienna Biopharmaceuticals

Sienna Biopharmaceuticals Prices Public Offering of Common Stock

WESTLAKE VILLAGE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten...

Sienna Biopharmaceuticals Reports First Quarter 2019 Financial Results

-- Company Completed Positive End-of-Phase 2 Meeting with FDA for SNA-120 in Psoriasis WESTLAKE VILLAGE, Calif., May 08, 2019 (GLOBE NEWSWIRE) --  Sienna Biopharmaceuticals, Inc. (Nasdaq:SNN...

Sienna Biopharmaceuticals to Present at Dermatology Drug Development Summit Europe

WESTLAKE VILLAGE, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Paul F. Lizzul, M.D., Ph.D...

Sienna Biopharmaceuticals Announces Proposed Public Offering of Common Stock

WESTLAKE VILLAGE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that it has commenced a propos...

Sienna Biopharmaceuticals® to Present at Dermatology Summit and J.P. Morgan Healthcare Conference

WESTLAKE VILLAGE, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Execut...

Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

WESTLAKE VILLAGE, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today reported the Company’s financial resu...

Sienna Biopharmaceuticals (SNNA) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Cubicin [oso biopharmaceuticals manufacturing, llc]

Drug Listing for CDF Product Code

Na [nabi biopharmaceuticals]

NA

Kit for the preparation of lymphoseek (technetium tc 99m tilmanocept) [navidea biopharmaceuticals, inc.]

These highlights do not include all the information needed to use LYMPHOSEEK safely and effectively. See full prescribing information for LYMPHOSEEK. Lymphoseek (technetium Tc 99m tilmanocept) injecti...

Kybella [kythera biopharmaceuticals inc.]

These highlights do not include all the information needed to use KYBELLA safely and effectively. See full prescribing information for KYBELLA .         KYBELLA ( d eoxycholic acid )   injectio...

PubMed Articles [30 Associated PubMed Articles listed on BioPortfolio]

Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals.

In chronic intestinal diseases like inflammatory bowel disease, parenteral administration of biopharmaceuticals is associated with numerous disadvantages including immune reactions, infections, low pa...

Acknowledgement to Referees.

Antibody-cytokine fusion proteins: a novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.

Antibody-cytokine fusion proteins represent a novel class of biopharmaceuticals, with the potential to increase the therapeutic index of cytokine 'payloads' and to promote leukocyte infiltration at th...

Co-delivery of TRAIL and siHSP70 using hierarchically modular assembly formulations achieves enhanced TRAIL-resistant cancer therapy.

The combined therapy of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and heat shock protein 70-targeting siRNA (siHSP70) has shown an improved anti-tumor effect on TRAIL-resistant t...

Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches.

Spray drying is increasingly becoming recognized as an efficient drying and formulation technique for pharmaceutical and biopharmaceutical processing. It offers significant economic and processing adv...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Sienna+® Injection Time Study 4 Arms

Patients with breast cancer normally undergo a labelling with radioactive tracer typically 1 day before surgery, which enables the surgeon to localize the sentinel lymph node during surger...

Sienna and Sentimag in Sentinel Lymph Node Biopsy

The aim of this study is to evaluate a new method for the localization of breast cancer sentinel lymph node using Sienna+® and Sentimag® detection in comparison to our standard technique...

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a l...

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Companies [193 Associated Companies listed on BioPortfolio]

Sienna Biopharmaceuticals

DiaSorin Incorporated

DiaSorin, formerly known as INCSTAR, SORIN Diagnostics, and Sienna Biotech along with Alimenterics make up the Medical Systems Group of American Standard Company. Now as one, we provide improved healt...

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...

More Information about "Sienna Biopharmaceuticals" on BioPortfolio

We have published hundreds of Sienna Biopharmaceuticals news stories on BioPortfolio along with dozens of Sienna Biopharmaceuticals Clinical Trials and PubMed Articles about Sienna Biopharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sienna Biopharmaceuticals Companies in our database. You can also find out about relevant Sienna Biopharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record